Show simple item record

dc.date.accessioned2023-07-03T11:23:29Z
dc.date.available2023-07-03T11:23:29Z
dc.date.issued2023-04
dc.identifier.urihttp://hdl.handle.net/10952/6541
dc.descriptionRandomized, double-blind, placebo-controlled clinical trial, to evaluate an oral probiotic effectiveness administered for 12 weeks on the hidradenitis suppurativa evolution. A total of 60 patients diagnosed with hidradenitis suppurativa will participate in the study, who will be randomized into two treatment groups in a 1:1 ratio (30 patients per group). The intervention groups are differentiated according to the treatment to be received: probiotic or placebo of similar appearance, along with standard therapy according to usual clinical practice. The 12 weeks of treatment are structured into three face-to-face visits: Visit 1 (initial; week 0), Visit 2 (intermediate; week 6) and Visit 3 (final; week 12).es
dc.description.abstractThe clinical trial has a randomized, double-blind, placebo-controlled design, which aims to evaluate the effect of an oral probiotic preparation administered for 12 weeks on the evolution of hidradenitis suppurativaes
dc.language.isoenes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectHidradenitis suppurativaes
dc.subjectAcne inversaes
dc.subjectOral probiotices
dc.subjectMicrobiotaes
dc.subjectMicrobiomees
dc.titleRandomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of an oral probiotic preparation in hidradenitis suppurativa treatmentes
dc.typeotheres
dc.rights.accessRightsopen accesses
dc.description.disciplineCiencias de la Alimentaciónes
dc.description.disciplineMedicinaes


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional